UK markets closed
NIKKEI 225
38,835.10 +599.03 (+1.57%) HANG SENG
18,479.37 -98.93 (-0.53%) CRUDE OIL
78.55 +0.07 (+0.09%) GOLD FUTURES
2,322.00 -9.20 (-0.39%) DOW
38,904.90 +52.63 (+0.14%) Bitcoin GBP
50,892.76 +129.66 (+0.26%)
VRTX Jan 2025 270.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 2.4000 |
| Open | 1.9500 |
| Bid | 0.1500 |
| Ask | 4.9000 |
| Strike | 270.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.9500 - 1.9500 |
| Contract range | N/A |
| Volume | |
| Open interest | 124 |
Investor's Business DailyVertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.
Insider MonkeyVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
- Thomson Reuters StreetEvents
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
Q1 2024 Vertex Pharmaceuticals Inc Earnings Call
© 2024 Yahoo. All rights reserved.